Ishikawa T, Suzuki M, Honma T, Yoshida T
Transl Gastroenterol Hepatol. 2025; 10:5.
PMID: 39944583
PMC: 11811561.
DOI: 10.21037/tgh-24-103.
Chen S, Huang L, Chu Y, Lian J, Shao H, Wang T
Sci Rep. 2025; 15(1):3031.
PMID: 39856182
PMC: 11760383.
DOI: 10.1038/s41598-025-87756-4.
Jaho J, Kamberi F, Mechili E, Bicaj A, Carni P, Baiocchi L
World J Virol. 2024; 13(4):93721.
PMID: 39722761
PMC: 11551693.
DOI: 10.5501/wjv.v13.i4.93721.
Said S, Shadaker S, McMahon B, Armstrong P, Beckett G, Kamili S
J Viral Hepat. 2024; 32(1):e14051.
PMID: 39707980
PMC: 11752844.
DOI: 10.1111/jvh.14051.
Ismael N, Usmael S, Belay N, Mekonen H, Johannessen A, Orlien S
World J Hepatol. 2024; 16(7):995-1008.
PMID: 39086536
PMC: 11287608.
DOI: 10.4254/wjh.v16.i7.995.
HBV elimination in Africa-Current status and challenges.
Sonderup M, Spearman C
Clin Liver Dis (Hoboken). 2024; 23(1):e0166.
PMID: 38707243
PMC: 11068139.
DOI: 10.1097/CLD.0000000000000166.
Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes.
Foko S
J Math Biol. 2024; 88(6):75.
PMID: 38689137
PMC: 11061075.
DOI: 10.1007/s00285-024-02096-7.
Evaluation of Tenofovir Disoproxil Fumarate Treatment in Patients with Chronic Hepatitis B.
Konya P, Demirturk N
Infect Dis Clin Microbiol. 2024; 4(1):47-54.
PMID: 38633545
PMC: 11022821.
DOI: 10.36519/idcm.2022.78.
Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac.
Freyre F, Aguiar J, Cinza Z, Figueroa N, Diaz P, Muzio V
Euroasian J Hepatogastroenterol. 2024; 13(2):73-78.
PMID: 38222949
PMC: 10785140.
DOI: 10.5005/jp-journals-10018-1402.
Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis.
Ai R, Li L, Yuan X, Zhao D, Miao T, Guan W
Histol Histopathol. 2024; 39(8):1025-1035.
PMID: 38197199
DOI: 10.14670/HH-18-695.
Point-of-Care Testing for Hepatitis Viruses: A Growing Need.
Pauly M, Ganova-Raeva L
Life (Basel). 2023; 13(12).
PMID: 38137872
PMC: 10744957.
DOI: 10.3390/life13122271.
Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses.
Xu Q, Ding H, Bai T, Huang R, Wang J, Zhang J
J Mol Histol. 2023; 54(6):739-749.
PMID: 37843699
DOI: 10.1007/s10735-023-10162-5.
Clinical Distribution Characteristics and Identification for Significant Liver Inflammation of Patients in Chronic Hepatitis B with Indeterminate Phase.
Chen S, Dai X, Zhao Y, Li J, Zou X, Huang H
Gastroenterol Res Pract. 2023; 2023:7264601.
PMID: 37469711
PMC: 10353904.
DOI: 10.1155/2023/7264601.
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
Jang H, Yu S, Lee H, Kim T, Lee Y, Cho E
J Korean Med Sci. 2023; 38(28):e216.
PMID: 37463687
PMC: 10353911.
DOI: 10.3346/jkms.2023.38.e216.
Prevalence of Hepatitis B Virus, Human Immune Deficiency Virus and Associated Risk Factors Among Individuals with Presumptive Pulmonary Tuberculosis Attending at Saint Peter's Specialized Hospital, Addis Ababa, Ethiopia.
Gebrehiwet K, Biranu E, Nigatu W, Gebreegziabher A, Desta K
Infect Drug Resist. 2023; 16:3965-3979.
PMID: 37366503
PMC: 10290864.
DOI: 10.2147/IDR.S410260.
Antigen Recognition and Immune Response to Acute and Chronic Hepatitis B Virus Infection.
Adugna A
J Inflamm Res. 2023; 16:2159-2166.
PMID: 37223107
PMC: 10202203.
DOI: 10.2147/JIR.S411492.
Health-Related Quality of Life in Patients with Chronic Hepatitis B: A Meta-Analysis of Observational Studies.
Saussakova S, Dauletova G, Nakipov Z, Sarsenbayeva G, Duisekova S, Sadibekova Z
Iran J Public Health. 2023; 52(3):453-462.
PMID: 37124905
PMC: 10135505.
DOI: 10.18502/ijph.v52i3.12129.
Factors associated with immunization against hepatitis B among primary health care professionals.
Mota G, Fernandes L, Fonseca L, Ferreira M, Mendes V, Lima C
Rev Bras Med Trab. 2023; 20(4):563-573.
PMID: 37101436
PMC: 10124812.
DOI: 10.47626/1679-4435-2022-790.
Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem.
Boora S, Sharma V, Kaushik S, Bhupatiraju A, Singh S, Kaushik S
Braz J Microbiol. 2023; 54(2):679-689.
PMID: 37059940
PMC: 10235410.
DOI: 10.1007/s42770-023-00970-y.
Global burden of hepatitis B virus: current status, missed opportunities and a call for action.
Hsu Y, Huang D, Nguyen M
Nat Rev Gastroenterol Hepatol. 2023; 20(8):524-537.
PMID: 37024566
DOI: 10.1038/s41575-023-00760-9.
